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Nuclear phosphoinositide metabolism has been widely described as involved 
in many regulatory mechanisms including cell cycle and cell proliferation (1). Our 
recent studies demonstrated that an increase of nuclear Diacylglycerol (DAG) regu-
lated the G2/M progression of erythroleukemia cells, K562 (2). As nuclear DAG can 
be synthesized by Phospholipases C (PLC) located in the nucleus, it can also be con-
verted to Phosphatidic acid (PA) by a class of proteins called Diacylglycerol Kinases 
(DGK), which phosphorylate it utilizing ATP as a source of phosphate. PA levels in 
the nuclear compartments peak after G2/M progression, controlling cell cycle pro-
gression (1). We found that a particular DGK isoform, DGKa, is highly localized 
in the nuclear compartment of K562 cells. Then, we decided to investigate if this 
isozyme could be involved in cell proliferation of K562 cells, stimulating the exit 
from G2/M checkpoint through the production of PA in the nuclear compartment. 
Our data show that inhibition of DGK activity by two specific inhibitors, DI (R59022) 
and DII (R59949), blocks K562 cell proliferation. This effect is probably due to nuclear 
DGKa, indeed its modulation can affect cell proliferation too. Moreover, many cell 
cycle related proteins seem to be targeted by DGK activity. These evidences suggest 
a role for DGKa in the control of cell cycle progression acting on nuclear DAG levels 
and increase our knowledge about the importance of PI metabolism in the nuclei of 
eucaryotic cells.
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